News

FDA names former pharmaceutical company executive to oversee US drug program
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
Biotech exec George Tidmarsh picked as FDA's chief drug regulator
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
FDA appoints biotech veteran George Tidmarsh to lead drug evaluation division
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
FDA Appoints Biotech Executive as Top Drug Regulator Under RFK Jr.
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
FDA appoints George Tidmarsh as top drug regulator
By Sriparna Roy and Sneha S K (Reuters) -The U.S. Food and Drug Administration said on Monday it has appointed George ...
FDA taps biotech industry veteran as RFK Jr.'s top drug regulator
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
Joint Director, Food and Drug Administration caught red-handed while receiving bribe ₹25,000
DVAC arrests Joint Director of Drugs Control for demanding bribe from soap factory proprietor, caught red-handed.
Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug program
Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...
STAT30m
New head of FDA drug center is a biotech veteran and an outspoken critic of the academic establishment
The Food and Drug Administration on Monday named George Tidmarsh, a longtime biotech executive who has a background in ...
RedHill Biopharma Rises After Positive FDA Feedback on Crohn's Drug
American depositary receipts of RedHill Biopharma climbed after the company said it received positive Food and Drug Administration feedback on its treatment for Crohn's disease. The ADRs were up 24%, ...